V1 sact_drug_detail
6,385,827 rows · 11 columns
| MERGED_DRUG_DETAIL_ID | MERGED_CYCLE_ID | ORG_CODE_OF_DRUG_PROVIDER | ACTUAL_DOSE_PER_ADMINISTRATION | OPCS_DELIVERY_CODE | ADMINISTRATION_ROUTE | ADMINISTRATION_DATE | DRUG_GROUP | MERGED_PATIENT_ID | MERGED_TUMOUR_ID | MERGED_REGIMEN_ID |
|---|---|---|---|---|---|---|---|---|---|---|
| 10020833 | 10021688 | EON | 20 | null | 5 | 2017-04-28 | NOT CHEMO | 10505925 | 10002545 | 10004036 |
| 10020834 | 10021689 | EU8 | 1000 | X741 | 2 | 2018-09-02 | ABIRATERONE | 10505927 | 10002546 | 10004037 |
| 10020835 | 10021691 | EOY14 | 30 | X723 | 2 | 2016-10-28 | CYCLOPHOSPHAMIDE | 10506127 | 10002551 | 10004042 |
| 10020836 | 10021692 | ERA20 | 1000 | X723 | 2 | 2018-08-13 | ABIRATERONE | 10506212 | 10002554 | 10004045 |
| 10020837 | 10021693 | ERA20 | 1000 | null | null | 2018-06-08 | ABIRATERONE | 10506303 | 10002556 | 10004047 |
| 10020838 | 10021694 | EQ1 | null | X723 | null | 2017-11-16 | CYCLOPHOSPHAMIDE | 10506342 | 10002557 | 10004049 |
| 10020839 | 10021695 | EQH01 | 0 | X731 | 2 | 2015-01-02 | IMATINIB | 10506342 | 10002557 | 10004050 |
| 10020840 | 10021696 | EGQ01 | 1000 | X723 | 2 | 2017-12-31 | ABIRATERONE | 10506420 | 10002558 | 10004051 |
| 10020841 | 10021697 | ENR01 | 1000 | X731 | 2 | 2016-11-23 | ABIRATERONE | 10506420 | 10002558 | 10004052 |
| 10020842 | 10021698 | EGQ01 | 200 | null | 2 | 2016-12-15 | THALIDOMIDE | 10506602 | 10002559 | 10004054 |
| 10020843 | 10021699 | EGQ01 | 6000 | X731 | 2 | 2013-10-17 | STEROID | 10506662 | 10002561 | 10004056 |
| 10020844 | 10021700 | ENR01 | 1000 | X731 | 2 | 2016-08-22 | ABIRATERONE | 10506691 | 10008154 | 10004058 |
| 10020845 | 10021701 | EGQ01 | 1000 | X723 | 2 | 2017-03-14 | BORTEZOMIB | 10506707 | 10002562 | 10004059 |
| 10020846 | 10021702 | EGQ01 | null | null | 2 | 2019-04-13 | IMATINIB | 10506721 | 10002563 | 10004060 |
| 10020847 | 10021703 | ENR01 | 400 | X731 | 1 | 2018-01-27 | ABIRATERONE | 10506721 | 10002563 | 10004061 |
| 10020848 | 10021704 | EGQ01 | 1000 | X741 | 2 | 2016-03-21 | ABIRATERONE | 10506788 | 10002566 | 10004064 |
| 10020849 | 10021705 | ENR01 | 1000 | X723 | 2 | 2018-05-19 | ABIRATERONE | 10506788 | 10002566 | 10004066 |
| 10020850 | 10021706 | EUDUU | 400 | X721 | 2 | 2014-03-21 | THALIDOMIDE | 10506951 | 10008826 | 10004067 |
| 10020851 | 10021707 | ESFQN | 500 | X731 | 5 | 2017-06-08 | CYCLOPHOSPHAMIDE | 10506952 | 10009109 | 10004068 |
| 10020852 | 10021708 | EAD51 | 3.5 | null | 2 | 2019-04-04 | CYCLOPHOSPHAMIDE | 10506999 | 10002570 | 10004072 |
| 10020853 | 10021709 | EUDUU | 300 | X731 | 2 | 2018-07-11 | ZOLEDRONIC ACID | 10507008 | 10002571 | 10004073 |
| 10020854 | 10021710 | ESFQN | 20 | X723 | 2 | 2013-08-14 | STEROID | 10507066 | 10002572 | 10004074 |
| 10020855 | 10021711 | EA325 | 28000 | X723 | 2 | null | ABIRATERONE | 10507092 | 10002573 | 10004075 |
| 10020856 | 10021712 | EN710 | 1000 | X741 | null | 2019-02-08 | STEROID | 10507264 | 10002576 | 10004079 |
| 10020857 | 10021713 | ERS12 | 1000 | X723 | 2 | 2016-08-19 | ABIRATERONE | 10507270 | 10002578 | 10004081 |
| 10020858 | 10021714 | EW100 | 1000 | X723 | 2 | null | ABIRATERONE | 10507739 | 10002589 | 10004095 |
| 10020859 | 10021715 | EW100 | 1000 | X731 | 2 | 2018-04-12 | STEROID | 10507760 | 10002590 | 10004096 |
| 10020860 | 10021716 | EW100 | 1000 | X731 | 2 | 2018-04-24 | ABIRATERONE | 10507854 | 10006575 | 10004099 |
| 10020861 | 10021717 | EDZ01 | 1000 | null | 2 | 2017-06-05 | ABIRATERONE | 10507871 | 10002592 | 10004100 |
| 10020862 | 10021719 | EN201 | 1000 | X723 | 2 | 2017-10-03 | ABIRATERONE | 10508264 | 10002599 | 10004109 |
| 10020863 | 10021720 | EJR | 28000 | null | 2 | 2018-09-03 | ABIRATERONE | 10508264 | 10002599 | 10004110 |
| 10020864 | 10021721 | EJR | 1000 | X731 | 2 | 2017-12-17 | ABIRATERONE | 10508428 | 10002602 | 10004113 |
| 10020865 | 10021722 | EJR | 2.25 | X731 | 5 | 2017-12-06 | CYCLOPHOSPHAMIDE | 10508447 | 10006579 | 10004114 |
| 10020866 | 10021723 | EJR | 1000 | X731 | 2 | 2018-02-28 | ABIRATERONE | 10508478 | 10002603 | 10004118 |
| 10020867 | 10021724 | ERS12 | 2 | X723 | 2 | 2016-11-09 | BORTEZOMIB | 10508669 | 10002604 | 10004119 |
| 10020868 | 10021725 | EA325 | 3.5 | X731 | 2 | 2018-10-31 | CYCLOPHOSPHAMIDE | 10508669 | 10002604 | 10004120 |
| 10020869 | 10021726 | EN201 | 750 | X723 | 1 | 2015-12-09 | ABIRATERONE | 10508669 | 10002604 | 10004121 |
| 10020870 | 10021727 | EEI00 | 150 | null | 1 | 2016-09-26 | BORTEZOMIB | 10508782 | 10002607 | 10004124 |
| 10020871 | 10021728 | EW100 | 1000 | X723 | 2 | 2017-10-26 | CYCLOPHOSPHAMIDE | 10508927 | 10002609 | 10004130 |
| 10020872 | 10021729 | EN201 | 1000 | null | 2 | 2019-03-04 | ABIRATERONE | 10508982 | 10002610 | 10004131 |
| 10020873 | 10021730 | EN201 | 12000 | null | 2 | 2015-04-02 | ABIRATERONE | 10509263 | 10002614 | 10004138 |
| 10020874 | 10021731 | EA325 | null | null | 2 | 2017-12-05 | ZOLEDRONIC ACID | 10509305 | 10002615 | 10004141 |
| 10020875 | 10021732 | ENR01 | 1000 | null | 2 | 2016-03-05 | ABIRATERONE | 10509678 | 10002619 | 10004145 |
| 10020876 | 10021733 | ED8Y0 | 2 | X723 | 1 | 2018-05-14 | NOT CHEMO | 10509834 | 10002623 | 10004152 |
| 10020877 | 10021734 | EJU04 | 500 | X723 | 2 | 2019-01-29 | NOT MATCHED | 10509858 | 10002626 | 10004156 |
| 10020878 | 10021735 | EJU04 | 1000 | null | 2 | 2015-02-10 | ABIRATERONE | 10509858 | 10002626 | 10004157 |
| 10020879 | 10021736 | ETG | 350 | null | 1 | 2018-08-20 | ABIRATERONE | 10510275 | 10008829 | 10004162 |
| 10020880 | 10021737 | ENW | 1000 | null | 5 | null | IMATINIB | 10510319 | 10002629 | 10004164 |
| 10020881 | 10021738 | ETG01 | null | X723 | 5 | 2018-02-07 | STEROID | 10510595 | 10002631 | 10004166 |
| 10020882 | 10021739 | ENW | 1000 | X731 | 2 | 2015-06-02 | STEROID | 10510766 | 10002633 | 10004168 |